Skip to main content

Market Overview

15 Biggest Mid-Day Gainers For Friday

  • EnteroMedics Inc (NASDAQ: ETRM) shares surged 73.3 percent to $6.88. EnteroMedics shares have jumped 120.56 percent over the past 52 weeks, while the S&P 500 index has gained 14.01 percent in the same period.
  • SunLink Health Systems, Inc. (NYSE: SSY) shares jumped 30.4 percent to $1.46. SunLink Health announced plans to buyback 3 million shares at $1.50 per share.
  • Zafgen Inc (NASDAQ: ZFGN) shares jumped 21.2 percent to $4.06g after gaining 0.60 percent on Thursday.
  • Quotient Ltd (NASDAQ: QTNT) shares gained 16.7 percent to $6.29 after the company reported positive MosaiQ results from its performance evaluation study.
  • Stemline Therapeutics Inc (NASDAQ: STML) shares climbed 14.2 percent to $12.96 after the company reported a FDA deal on expedited pathway to full approval of SL-401 in first-line BPDCN.
  • Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares surged 14.2 percent to $39.00. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.
  • Cempra Inc (NASDAQ: CEMP) shares gained 12.3 percent to $3.65.
  • Abeona Therapeutics Inc (NASDAQ: ABEO) climbed 6.7 percent to $5.97. Jefferies initiated coverage on Abeona Therapeutics with a Buy rating.
  • Healthways, Inc. (NASDAQ: HWAY) shares rose 6.5 percent to $24.75. Jefferies upgraded Healthways from Hold to Buy.
  • Helen of Troy Limited (NASDAQ: HELE) shares climbed 6.4 percent to $95.00. Helen of Troy reported better-than-expected earnings for its third quarter, but sales missed expectations. The company raised its earnings forecast for the year, but lowered its sales outlook.
  • Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares gained 5.5 percent to $49.66 after the company reported a licensing deal with Novartis AG (ADR) (NYSE: NVS).
  • CTI BioPharma Corp (NASDAQ: CTIC) shares rose 4.5 percent to $4.66 after surging 12.34 percent on Thursday.
  • Neurocrine Biosciences, Inc. (NASDAQ: NBIX) shares rose 4.4 percent to $43.19. Neurocrine issued an update on FDA Advisory Committee for INGREZZA for the treatment of tardive dyskinesia.
  • Amgen, Inc. (NASDAQ: AMGN) rose 3.3 percent to $157.96 after the company disclosed that it has won a court ruling for a ban on Sanofi's sales of praluent cholestrol drug.
  • Gap Inc (NYSE: GPS) rose 2.4 percent to $23.80. Gap reported a 2 percent year-over-year gain in its comparable sales for the November and December 2016 holiday season. Gap comparable sales for December rose 4 percent, compared to a 5 percent decline last year.

Related Articles (SSY + ETRM)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at